Opus Genetics, Inc. (IRD) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$6.47M2010: -$10.31M2011: -$16.13M2012: -$6.58M2013: -$7.98M2014: -$13.27M2015: -$18.26M2016: -$16.41M2017: -$17.35M2018: -$20.54M2019: -$4.19M2020: -$19.97M2021: -$22.70M2022: $18.23M2023: -$10.56M2024: -$62.07M2025: -$38.60M-$38.60M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$38.60M+37.8%
2024-$62.07M-487.7%
2023-$10.56M-158.0%
2022$18.23M+180.3%
2021-$22.70M-13.7%
2020-$19.97M-376.2%
2019-$4.19M+79.6%
2018-$20.54M-18.3%
2017-$17.35M-5.7%
2016-$16.41M+10.1%
2015-$18.26M-37.6%
2014-$13.27M-66.3%
2013-$7.98M-21.3%
2012-$6.58M+59.2%
2011-$16.13M-56.5%
2010-$10.31M-59.4%
2009-$6.47M